Clinical trial 1206 - HNCG
A randomized phase II study to evaluate the efficacy and safety of Chemotherapy (CT) vs androgen deprivation therapy (ADT) in patients with recurrent and/or metastatic, androgen receptor (AR) expressing, salivary gland cancer (SGCs)
| Cancers | |
|---|---|
| Organ | Oral cavity and lips |
| Trial status | Trial closed for recruitment |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 2 |
| Academic trial | Non |
| Sponsor | EORTC |
| EudraCT Identifier | 2013-000314-38 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT01969578 |
| Inclusion criteria | metastatic RECIST 1.1 |
| Last update |